Enterprise Value
21.65M
Cash
16.19M
Avg Qtr Burn
-4.108M
Short % of Float
2.00%
Insider Ownership
20.82%
Institutional Own.
10.41%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
GT-02287 Details Parkinson's disease | Phase 1 Initiation |